N-[(4-Fluorophenyl)methyl]-2-hydroxyacetamide

Catalog No.: 
ACLVRQ424
CAS No.: 
1153759-06-8
Molecular Formula: 
C9H10FNO2
Molecular Weight: 
183.18
N-[(4-Fluorophenyl)methyl]-2-hydroxyacetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$132.00InquiryInquiry
100mg95%$188.00InquiryInquiry
250mg95%$261.00InquiryInquiry
1g95%$623.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-[(4-Fluorophenyl)methyl]-2-hydroxyacetamide
IUPAC NameN-(4-fluorobenzyl)-2-hydroxyacetamide
MDL No.MFCD12138145
Molecular FormulaC9H10FNO2
Molecular Weight183.18
SMILESO=C(NCC1=CC=C(F)C=C1)CO
InChI KeyQSERADXKQLENBX-UHFFFAOYSA-N
SynonymN-[(4-Fluorophenyl)methyl]-2-hydroxyacetamide;Acetamide, N-[(4-fluorophenyl)methyl]-2-hydroxy-
CAS No.1153759-06-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACLVRQ424 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHQGZ976 route compound structure diagram
    ACHQGZ976659-41-6In Stock
  2. Plus
  3. ACBXCF471 route compound structure diagram
    ACBXCF4712836-32-0In Stock
  4. Then
  5. ACLVRQ424 route product structure diagram
    ACLVRQ4241153759-06-8
Inquiry

2. ACLVRQ424 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHQGZ976 route compound structure diagram
    ACHQGZ976659-41-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLVRQ424 route product structure diagram
    ACLVRQ4241153759-06-8
Inquiry

3. ACLVRQ424 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLVRQ424 route product structure diagram
    ACLVRQ4241153759-06-8
Inquiry

Comments (0)